Lacerda B. De Oliveira
Fortaleza, CE, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Associations Between APOE Polymorphisms, Neurological Symptoms, and Cognitive Assessments in Long COVID Patients: An Analysis of SNPs rs7412 and rs429358.
Journal: Molecular neurobiology
Published: April 30, 2025
Hyperexpression of PTAFR and PF4 as Possible Platelet Risk Biomarkers in Patients With COVID-19.
Journal: In vivo (Athens, Greece)
Published: July 04, 2024
Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?
Journal: Brain sciences
Published: October 25, 2023
Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
Journal: Toxicology and applied pharmacology
Published: April 18, 2023
Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer.
Journal: Pharmaceutics
Published: July 20, 2022
Long-covid cognitive impairment: Cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort.
Journal: Frontiers in psychiatry
Published: May 25, 2022
Anticancer potential of mebendazole against chronic myeloid leukemia: in silico and in vitro studies revealed new insights about the mechanism of action.
Journal: Frontiers in pharmacology
Published: May 24, 2022
Genomic surveillance: Circulating lineages and genomic variation of SARS-CoV-2 in early pandemic in Ceará state, Northeast Brazil.
Journal: Virus research
Published: March 24, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026